Inhaled gene therapy trial aims to shrink early lung nodules, could offer Non-Surgical option
NCT ID NCT07150416
Summary
This study is testing whether inhaling a gene therapy drug called Gendicine can safely shrink or control multiple early-stage lung nodules. It will enroll about 38 adults with these nodules, which are often precancerous or early cancer. All participants will receive the inhaled treatment, and doctors will use regular CT scans to see if the nodules get smaller.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, 510120, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.